Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Healthcare Industry News Ryania: A natural pesticide transforming modern agriculture Ryania speciosa, commonly known as Ryania or Ryanicide, is a plant native to South America that has been… bypharmanewsdailyJanuary 18, 2025